UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Synchronous Melanoma and Pancreas Malignancies Leading to a Discovery of a CDKN2A Mutation in a Patient with No Known Family History

Case reports in oncology, 2021-01, Vol.14 (1), p.333-337

2021

Volltextzugriff (PDF)

Pancreatic Cancer: BRCA Targeted Therapy and Beyond

Cancers, 2023-05, Vol.15 (11), p.2955

2023

Volltextzugriff (PDF)

Dramatic, durable response to therapy in gBRCA2-mutated pancreas neuroendocrine carcinoma: opportunity and challenge

NPJ precision oncology, 2023-04, Vol.7 (1), p.40-40, Article 40

2023

Volltextzugriff (PDF)

115 Comprehensive spatial, transcriptomic, and genomic analysis of immunogenic biliary tract cancer

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A130-A131

2023

Volltextzugriff (PDF)

Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma

Cancer medicine (Malden, MA), 2020-01, Vol.9 (2), p.469-475

2020

Volltextzugriff (PDF)

Gonadotropin-releasing hormone agonist-induced pituitary apoplexy

Endocrinology, diabetes & metabolism case reports, 2016-01, Vol.2016, p.160021-160021

2016

Volltextzugriff (PDF)

Immune checkpoint inhibitor therapy in locally advanced MSI GI malignancies

Clinical advances in hematology & oncology, 2024-05, Vol.22 (4), p.162

2024

Volltextzugriff (PDF)

Genomic landscape of acquired resistance to targeted therapies in metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.190-190

2023

Volltextzugriff (PDF)

Incidence of Pancreatic Cancer by Age and Sex in the US From 2000 to 2018

JAMA : the journal of the American Medical Association, 2022-04, Vol.327 (14), p.1401

2022

Volltextzugriff (PDF)

Clinical Utility of 18 F-2-Fluoro-deoxy-d-glucose PET Imaging in Locally Advanced Esophageal/Gastroesophageal Junction Adenocarcinoma

Diagnostics (Basel), 2023-05, Vol.13 (11)

2023

Volltextzugriff (PDF)

Precision Approaches to Pancreatic Cancer Therapy: What Now and What Next?

Current treatment options in gastroenterology, 2022-06, Vol.20 (3), p.406-428

2022

Volltextzugriff (PDF)

A survey of colorectal cancer (CRC) survivorship practices in Ireland, and implementation of a survivorship care plan (SCP) pilot program

Journal of clinical oncology, 2018-03, Vol.36 (7_suppl), p.60-60

2018

Volltextzugriff (PDF)

Clinical Utility of [sup.18]F-2-Fluoro-deoxy-d-glucose PET Imaging in Locally Advanced Esophageal/Gastroesophageal Junction Adenocarcinoma

Diagnostics (Basel), 2023-05, Vol.13 (11)

2023

Volltextzugriff (PDF)

Pancreatic Cancer: IBRCA/I Targeted Therapy and Beyond

Cancers, 2023-05, Vol.15 (11)

2023

Volltextzugriff (PDF)

Homologous Recombination Deficiency in Pancreatic Cancer: Poly (ADP-ribose) Polymerase Inhibition, Checkpoint Inhibition, or a Combination of Both?

JCO precision oncology, 2022-06 (6)

2022

Volltextzugriff (PDF)

Clinical implications of microsatellite instability in mucinous colorectal cancer

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.657-657

2019

Volltextzugriff (PDF)

Comparison of immunohistochemistry and polymerase chain reaction for single gene vs multigene panel with next generation sequencing for identifying targetable mutations in non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.S43-S44

2021

Volltextzugriff (PDF)

Clinical outcomes for IDH1 mutant biliary tract cancer (BTC) treated with contemporary systemic therapy

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.513-513

2023

Volltextzugriff (PDF)

Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease

JNCI : Journal of the National Cancer Institute, 2024-09, Vol.116 (9), p.1429-1438

2024

Volltextzugriff (PDF)

Molecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal Cancer

Clinical cancer research, 2024-06, p.OF1-OF12

2024

Volltextzugriff (PDF)

Long-term survival outcomes with immune checkpoint inhibitors (ICI) in metastatic uveal melanoma (MUM)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e21585-e21585

2021

Volltextzugriff (PDF)

Functional impact of somatic mutations in early-onset (EO) versus average onset (AO) microsatellite stable (MSS) stage III colorectal cancer (CRC)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3613-3613

2022

Volltextzugriff (PDF)

Prostate-specific membrane antigen (PSMA) PET-CT imaging in the investigation and management of biochemical recurrence in prostate cancer

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.208-208

2018

Volltextzugriff (PDF)

Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 Mutation

Oncology research and treatment, 2023-05, Vol.46 (5), p.211-215

2023

Volltextzugriff (PDF)

Clinical utility of next generation sequencing (NGS) on circulating tumor DNA (ctDNA) in patients (pts) with pancreatic cancer (PC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4154-4154

2023

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(65)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Synchronous Melanoma and Pancreas Malignancies Leading to a Discovery of a CDKN2A Mutation in a Patient with No Known Family History

Pancreatic Cancer: BRCA Targeted Therapy and Beyond

Dramatic, durable response to therapy in gBRCA2-mutated pancreas neuroendocrine carcinoma: opportunity and challenge

115 Comprehensive spatial, transcriptomic, and genomic analysis of immunogenic biliary tract cancer

Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma

Gonadotropin-releasing hormone agonist-induced pituitary apoplexy

Immune checkpoint inhibitor therapy in locally advanced MSI GI malignancies

Genomic landscape of acquired resistance to targeted therapies in metastatic colorectal cancer (mCRC)

Incidence of Pancreatic Cancer by Age and Sex in the US From 2000 to 2018

Clinical Utility of 18 F-2-Fluoro-deoxy-d-glucose PET Imaging in Locally Advanced Esophageal/Gastroesophageal Junction Adenocarcinoma

Precision Approaches to Pancreatic Cancer Therapy: What Now and What Next?

A survey of colorectal cancer (CRC) survivorship practices in Ireland, and implementation of a survivorship care plan (SCP) pilot program

Clinical Utility of [sup.18]F-2-Fluoro-deoxy-d-glucose PET Imaging in Locally Advanced Esophageal/Gastroesophageal Junction Adenocarcinoma

Pancreatic Cancer: IBRCA/I Targeted Therapy and Beyond

Homologous Recombination Deficiency in Pancreatic Cancer: Poly (ADP-ribose) Polymerase Inhibition, Checkpoint Inhibition, or a Combination of Both?

Clinical implications of microsatellite instability in mucinous colorectal cancer

Comparison of immunohistochemistry and polymerase chain reaction for single gene vs multigene panel with next generation sequencing for identifying targetable mutations in non-small cell lung cancer

Clinical outcomes for IDH1 mutant biliary tract cancer (BTC) treated with contemporary systemic therapy

Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease

Molecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal Cancer

Long-term survival outcomes with immune checkpoint inhibitors (ICI) in metastatic uveal melanoma (MUM)

Functional impact of somatic mutations in early-onset (EO) versus average onset (AO) microsatellite stable (MSS) stage III colorectal cancer (CRC)

Prostate-specific membrane antigen (PSMA) PET-CT imaging in the investigation and management of biochemical recurrence in prostate cancer

Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 Mutation

Clinical utility of next generation sequencing (NGS) on circulating tumor DNA (ctDNA) in patients (pts) with pancreatic cancer (PC)

Suchergebnisse filtern